Neuronetics, Inc. (NASDAQ:STIM) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Neuronetics First Quarter 2026 Financial and Operating Results Call.
Neuronetics Inc. (STIM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Balyasny Asset Management Dmitry Balyasny | 2,743,768 | $3,978,464 | +8% | 0.01% |
| 2. | FourWorld Capital Management John Addis | 1,489,322 | $2,159,517 | +60% | 1.1% |
| 3. | Masters Capital Management Mike Masters | 1,000,000 | $1,450,000 | 0.05% | |
| 4. | Ikarian Capital Neil Shahrestani | 701,182 | $1,016,714 | 0.08% | |
| 5. | Wexford Capital Charles Davidson | 700,961 | $1,016,393 | +9% | 0.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.17 | 100,000 | $117,000.00 | 10,553,988 | 2026-05-19 | Filing | |
| $1.34 | 475,000 | $636,500.00 | 10,453,988 | 2026-05-12 | Filing | |
| $1.51 | 100,000 | $151,000.00 | 9,978,988 | 2026-04-21 | Filing | |
| $1.58 | 100,000 | $158,000.00 | 9,878,988 | 2026-04-20 | Filing | |
| $1.25 | 385,442 | $481,802.50 | 9,778,988 | 2026-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.34 | 8,569 | $11,482.46 | 836,643 | 2026-03-19 | Filing | |
| $1.34 | 16,431 | $22,017.54 | 828,781 | 2026-03-19 | Filing | |
| $1.34 | 46,289 | $62,027.26 | 1,590,924 | 2026-03-19 | Filing | |
| $1.34 | 16,005 | $21,446.70 | 897,270 | 2026-03-19 | Filing | |
| $1.34 | 609 | $816.06 | 879,525 | 2026-03-04 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,550 | $35,815 | 0.02% | |
| 2. | 681 | $885 | 0% | |
| 3. | 0 | $0 | 0% |
News See All
Neuronetics, Inc. (NASDAQ:STIM) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Neuronetics, Inc. Reports Fourth Quarter 2025 Financial and Operating Results.
Neuronetics, Inc. (NASDAQ:STIM) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Neuronetics Third Quarter 2025 Earnings Conference Call.
13 Best Psychedelic Stocks to Invest in Now
Unlike drugs such as cocaine or marijuana, psychedelics create an “alternate reality” by altering feelings, thoughts, and energy levels.
Neuronetics, Inc. (NASDAQ:STIM) Q2 2025 Earnings Call Transcript
Operator: Welcome to the Neuronetics Reports Second Quarter 2025 Financial and Operating Results. [Operator Instructions] Please be advised that today's conference is being recorded.
Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting
Neuronetics Inc. (NASDAQ:STIM) is one of the best-performing NASDAQ stocks according to analysts.
12 Best Performing NASDAQ Stocks According to Analysts
On July 3, Dan Ives, the Global Head of Tech Research at Wedbush, appeared on CNBC to suggest that AI will fuel a multi-year tech rally. Ives stated that he believes they are only at the beginning of...
Neuronetics, Inc. (NASDAQ:STIM) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Neuronetics First Quarter 2025 Financial and Operating Results Conference Call.
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
Hedge Fund Resource Center